Background Despite proven safety and efficacy, rates of laparoscopy for rectal cancer in the US are low. With reports of inferiority with laparoscopy compared to open surgery, and movements to develop accredited centers, investigating utilization and predictors of laparoscopy are warranted. Our goal was to evaluate current utilization and identify factors impacting use of laparoscopic surgery for rectal cancer. Methods The Premier TM Hospital Database was reviewed for elective inpatient rectal cancer resections (1/1/2010-6/ 30/2015). Patients were identified by ICD-9-CM diagnosis codes, and then stratified into open or laparoscopic approaches by ICD-9-CM procedure codes or billing charge. Logistic multivariable regression identified variables predictive of laparoscopy. The Cochran-Armitage test assessed trend analysis. The main outcome measures were trends in utilization and factors independently associated with use of laparoscopy. Results 3336 patients were included-43.8% laparoscopic (n = 1464) and 56.2% open (n = 1872). Use of laparoscopy increased from 37.6 to 55.3% during the study period (p \ 0.0001). General surgeons performed the majority of all resections, but colorectal surgeons were more likely to approach rectal cancer laparoscopically (41.31 vs. 36 The safety and feasibility of laparoscopy was first proven for colon cancer [11] [12] [13] [14] [15] [16] [17] [18] [19] ; then, controlled studies were extended to rectal cancer. Several large case series and single-institution trials showed that laparoscopy was safe and feasible for rectal cancer [20] . Results from the COLOR II, COREAN, and MRC CLASICC randomizedcontrolled trials supported equivalent outcomes for laparoscopic and open rectal cancer resections [16, [21] [22] [23] [24] [25] . Findings from recent studies questioned these results. The long-term outcomes from the ALaCaRT and ASOCOG Z6051 trials demonstrated laparoscopic resection failed to meet the criterion for non-inferiority compared with open surgery in curative rectal cancer resections [26, 27] . With this lack of support for routine use of laparoscopic surgery, and movements to standardize techniques and develop centers of excellence, investigating current utilization and predictors of laparoscopy for rectal cancer resection are warranted.
and limits in instrumentation and visibility [4] [5] [6] [7] [8] . While the technique is difficult, no compromises in patient safety or oncological outcomes, including rate of conservative sphincter surgery, length of hospital stay, post-surgical complications, number of affected/isolated lymph nodes or affected circumferential and distal margins, were reported during the learning curve for laparoscopic rectal cancer resections [9] . Another key reason for lower than expected utilization may be that the oncologic and long-term safety of the technique was unclear [10] .
The safety and feasibility of laparoscopy was first proven for colon cancer [11] [12] [13] [14] [15] [16] [17] [18] [19] ; then, controlled studies were extended to rectal cancer. Several large case series and single-institution trials showed that laparoscopy was safe and feasible for rectal cancer [20] . Results from the COLOR II, COREAN, and MRC CLASICC randomizedcontrolled trials supported equivalent outcomes for laparoscopic and open rectal cancer resections [16, [21] [22] [23] [24] [25] . Findings from recent studies questioned these results. The long-term outcomes from the ALaCaRT and ASOCOG Z6051 trials demonstrated laparoscopic resection failed to meet the criterion for non-inferiority compared with open surgery in curative rectal cancer resections [26, 27] . With this lack of support for routine use of laparoscopic surgery, and movements to standardize techniques and develop centers of excellence, investigating current utilization and predictors of laparoscopy for rectal cancer resection are warranted.
Our goal was to evaluate the current utilization and identify factors impacting use of laparoscopic surgery for rectal cancer. Our hypothesis was that by identifying these factors, surgeons could proactively work to safely increase laparoscopic approaches and surgical quality for rectal cancer patients.
Methodology and materials
The Premier Hospital Database (Premier, Charlotte, NC, USA) was reviewed from January 1, 2010 through June 30, 2015 to identify patients with rectal cancer who underwent elective rectal resection. The Premier Hospital Database represents approximately 1 out of every 5 United States inpatient hospital discharges, and is one of the largest hospital-level resource utilization and economic databases in the U.S. Specifically, there are approximately 600 hospitals contributing data on over 5 million inpatient discharges per year. Hospitals included in the database are a national representation in terms of regional distribution, urban versus rural hospital, teaching versus non-teaching institutions, and hospital bed size. Discharge-level data includes information on patient and provider characteristics, International Classification of Diseases 9th revision Clinical Modification (ICD-9-CM) diagnosis and procedure codes, hospital resource utilization such as specific device usage, medications and laboratory services, and charges/cost data on all entries.
Rectal [28] . Adjusted odds ratios (OR) were reported for all the predictors included in the model, along with 95% confidence interval and p value. The Cochran-Armitage test was used for trend analysis. P value less than 0.05 was considered as statistically significance. All analyses were performed using SAS software, version 9.4 (Cary, NC).
The data in Premier are de-identified and compliant with the Health Insurance Portability and Accountability Act (HIPAA), and therefore exempt from Institutional Review Board (IRB) approval (45 CFR §46.001(b) [4] ).
Results 3336 patients were included in the analysis-43.8% laparoscopic (n = 1464) and 56 .2% open (n = 1872). Overall, the use of laparoscopy steadily increased from 37.6 to 55.3% during the study period (p \ 0.0001). There were inherent differences in the patients undergoing each approach (Table 1) . The laparoscopic cohort patients were significantly younger (p \ 0.001), with lower disease severity (p \ 0.001), and more privately insured patients than the open cohort (p \ 0.001). General surgeons performed the majority of all resections, but colorectal surgeons were more likely to approach rectal cancer laparoscopically ( 
Discussion
This is a turbulent time for laparoscopic surgery for rectal cancer. Early reports showed safety and efficacy of laparoscopy for curative rectal cancer resection, with equivalent oncologic endpoints [20, [29] [30] [31] [32] [33] [34] [35] ; controlled trials then affirmed similar 3-year overall survival, diseasefree survival, and local recurrence compared to open surgery [16, [21] [22] [23] [24] [25] . The adoption of minimally invasive approaches for rectal cancer resection continued to lag behind colon cancer [36] . Then, recent reports of non-inferiority of laparoscopic resection compared with open resection for pathologic outcomes were published, concluding that there is not sufficient evidence for the routine use of laparoscopic surgery [26, 27] . Concurrently, there are national movements to improve outcomes and adherence to evidence-based guidelines through checklists, multidisciplinary tumor boards, and accredited centers of excellence [37] [38] [39] . With these activities, defining the utilization and predictors of laparoscopy are warranted. Our goal was to evaluate the current utilization and identify factors impacting use of laparoscopic surgery for rectal cancer. We found use of laparoscopy increased during the study period, from 37.6 to 55.3%. From our results, there were identifiable patient, surgeon, and hospital factors that independently impacted likelihood of receiving a laparoscopic resection for rectal cancer. With these factors identified, surgeons can proactively work to safely increase laparoscopic approaches and surgical quality for rectal cancer patients.
Our study is a unique addition to the literature as no prior study has looked at the individual variables that are independently associated with use of a laparoscopic approach for curative rectal cancer resection. However, aspects of our results agree with previously published studies for improving outcomes in general for rectal cancer resection. A greater likelihood of laparoscopy in younger, less comorbid patients was found, which is an expected results; these factors have been widely seen in studies for colorectal cancer and described as a predictor of laparoscopy in colon cancer, but not previously for rectal cancer [40] [41] [42] . In our study, surgeon specialty was an important predictive factor of laparoscopy, with colorectal surgeons 20% more likely to approach rectal cancer laparoscopically than general surgeons. While not focused on laparoscopy, prior studies have demonstrated the importance of surgeon specialization on outcomes, with colorectal surgeons and surgical oncologists having higher rates of restorative surgery [than colostomy formation] [43, 44] and improved overall survival in colorectal cancer [44] [45] [46] [47] . We also found geographic region was a significant predictor of use (and non-use) of laparoscopy, with the Midwest having the [48] . This variation in regional outcomes supports the development of rectal cancer centers of excellence in the US, where standardization could improve outcomes. Our strongest predictor of laparoscopy for rectal cancer was surgeon volume. No previous study has looked at surgeon volume specifically related to laparoscopic use. However, prior studies have shown the importance of volume on rectal cancer outcomes and surgical quality. Schrag et al. reported that surgeon volume was the most important predictor of long-term survival, and remained an important predictor even after adjustment for hospital volume [49] . Sphincter preservation has been reported as a surrogate for quality. Paquette et al. found the most important predictor for sphincter preservation was high procedural volume (OR 1.55, 95% CI [1.33-1.79], p \ 0.001) [50] [51] [52] . Riccardi et al. found 38.8% of surgeons in the US performed only non-restorative procedures for rectal cancer; outcomes for these surgeons showed significantly higher mortality and longer length of stay compared those who performed both restorative and non-restorative procedures [53] . In reviewing a state-wide database over 5 years, Baek et al. found only 8% (n = 24) of rectal cancer resections cases were performed at high-volume hospitals; however, there was significantly lower mortality and increased sphincter preservation in these higher volume centers [50] . The association between high-volume surgeons/centers and improved outcomes supports referral to high-volume centers of excellence [54] .
Development of rectal cancer centers of excellence could integrate all of the factors that impact outcomes. Success has been proven in international models that regionalized care, standardized teaching, and surgical techniques. The Norwegian Rectal Cancer Project increased the rate of total mesorectal excision, proportion of patients undergoing resection at high-volume hospitals, increased rates of neoadjuvant therapy, reduced local recurrence, and increased survival for rectal cancer nationwide [55, 56] . Similar improvements were seen with the Danish and Swedish National Rectal Cancer Registries, where care was centralized, local recurrence was reduced, and cancer-related survival increased [57] [58] [59] . The progression of regionalized centers of excellence and the National Accreditation Program for Rectal Cancer (NAPRC) could be a potential avenue to improve overall outcomes and safety expand utilization of laparoscopy for rectal cancer in the US [60] . We await the development of the NAPRC and evaluation of its impact.
We recognize the limitations of this study. The largest limitation was the retrospective study design, which has inherent limitations. We also used a national inpatient administrative data source, which has the potential for selection biases and coding errors. In this large sample size, we would not expect these to make a significant impact on our results or conclusions. Further, the sample size provided by the national inpatient data source was necessary to have the power to find significant differences across approaches and determine the predictive models. In the model, we included surgeon volume as a candidate predictor, but not hospital volume, under the assumption that surgeon volume is correlated with hospital volume and does not need to be an additional variable. However, it is possible that hospital volume could also be a significant factor. Future work will examine the impact of this variable.
In conclusion, we found the use of laparoscopy for rectal cancer has steadily increased over the years examined. Patient, provider, and regional variables exist, with hospital status, geographic location, and colorectal specialization impacting the likelihood receiving laparoscopic rectal cancer surgery. However, surgeon volume had the greatest influence. These results emphasize the importance of training and surgeon-specific outcomes to increase utilization, surgical quality, and improve patient recovery in appropriate cases.
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